SA JOURNAL OF DIABETES & VASCULAR DISEASE RESEARCH ARTICLE VOLUME 19 NUMBER 1 • July 2022 15 3. Turok I. Urbanisation and development in South Africa: economic imperatives, spatial distortions and strategic responses. (Urbanisation and Emerging Population Issues: Working Paper; 8). London: IIED 2012. 4. United Nations High Commission for Refugees. Global Strategy for Settlement and Shelter 2014. Available from: http://www.unhcr.org/530f13aa9.pdf [Accessed: 26/05/2020]. 5. Sverdlik A. Ill-health and poverty: a literature review on health in informal settlements. Environ Urban 2011; 23: 123–155. 6. Stephens C. Healthy cities or unhealthy islands? The health and social implications of urban inequality. Environ Urban 1996; 8: 9–30. 7. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Med 2006; 3: e442. 8. Ford ES, Caspersen CJ. Sedentary behaviour and cardiovascular disease: a review of prospective studies. Int J Epidem 2012; 41: 1338–1353. 9. Al Rifai M, DeFilippis AP, McEvoy JW, et al. The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2017; 258: 119–130. 10. Fung TT, Rimm EB, Spiegelman D, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73: 61–67. 11. Miranda JJ, Ordunez P, Di Cesare M. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet Glob Health 2020; 8: e123–33. 12. Leiter LA, Fitchett DH, Gilbert RE, et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011; 27: e1–e33. 13. Legetic B, Medici A, Hernández-Avila M, et al. A. Economic dimensions of noncommunicable disease in Latin America and the Caribbean. Disease control priorities. Companion volume. PAHO 2016. Available from: https://iris.paho.org/ handle/10665.2/28501. [Accessed: 20/03/2020]. 14. Gaziano TA, Abrahams-Gessel S, Gomez-Olive FX, et al. Cardiometabolic risk in a population of older adults with multiple co-morbidities in rural south africa: the HAALSI (Health and Aging in Africa: longitudinal studies of INDEPTH communities) study. BMC Public Health 2017; 17: 206. 15. Gómez-Olivé FX, Ali SA, Made F, et al. Regional and sex differences in the prevalence and awareness of hypertension: An H3Africa AWI-Gen study across 6 sites in sub-Saharan Africa. Glob Heart 2017; 12: 81–90. 16. Peltzer K and Phaswana-Mafuya N. Hypertension and associated factors in older adults in South Africa. Cardiovasc J Afr 2013; 24: 66. 17. National Department of Health (NDoH), Statistics South Africa (Stats SA), South African Medical Research Council (SAMRC), and ICF. 2019. SADHS 2016. Pretoria, South Africa, and Rockville, Maryland, USA: NDoH, Stats SA, SAMRC, and ICF. 18. Kruger MJ, Nell TA. The prevalence of the metabolic syndrome in a farm worker community in the Boland district, South Africa. BMC Public Health 2017; 17: 61. 19. Owolabi EO, Ter Goon D, Adeniyi OV, et al. Prevalence and correlates of metabolic syndrome among adults attending healthcare facilities in Eastern Cape, South Africa. TOPHJ 2017; 10. 20. Maimela E, Alberts M, Modjadji SE, et al. The prevalence and determinants of chronic non-communicable disease risk factors amongst adults in the Dikgale health demographic and surveillance system (HDSS) site, Limpopo Province of South Africa. PLoS One 2016; 11. 21. Manning K, Senekal M and Harbron J. Non-communicable disease risk factors and treatment preference of obese patients in Cape Town. Prim Health Care Fam Med 2016; 8: 1–12. 22. Thorogood M, Connor M, Tollman S, et al. A cross-sectional study of vascular risk factors in a rural South African population: data from the Southern African Stroke Prevention Initiative (SASPI). BMC Public Health 2007; 7: 326. 23. Bertram MY, Jaswal AV, van Wyk VP, et al. The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009. Glob Health Action 2013; 6: 19244. 24. Bradshaw D, Norman R, Pieterse D, et al. Estimating the burden of disease attributable to diabetes South Africa in 2000. S Afr Med J 2007; 97: 700–706. 25. Cameron AJ, Boyko EJ, Sicree RA, et al. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity 2008; 16: 2707–2716. 26. Barnard RJ, Roberts CK, Varon SM, et al. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 1998; 84: 1311–1315. 27. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366: 1059–1062. 28. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998; 15: 539– 553. 29. Erasmus RT, Soita DJ, Hassan MS, et al. High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: Baseline data of a study in Bellville, Cape Town. S Afr Med J 2012; 102: 841–844. 30. Motala AA, Esterhuizen T, Pirie FJ, et al. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care 2011; 34: 1032–1037. 31. Hoebel S, Malan L, De Ridder H. Differences in MetS marker prevalence between black African and Caucasian teachers from the North West Province: Sympathetic activity and ambulatory blood pressure in Africans (SABPA) Study. J Endocrinol Metab Dis S Afr 2011; 16: 49–56. 32. Sekgala M, Monyeki K, Mogale A, et al. The risk of metabolic syndrome as a result of lifestyle among Ellisras rural young adults. J Hum Hypertens 2018; 32: 572–584. 33. Sekokotla MA, Goswami N, Sewani-Rusike CR, et al. Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa. Ther Clin Risk Manag 2017; 13: 131. 34. Cornier M-A, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777–822. 35. Stern MP, Williams K, González-Villalpando C, et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676–2681. 36. Crowther NJ, Norris SA. The current waist circumference cut point used for the diagnosis of metabolic syndrome in sub-Saharan African women is not appropriate. PloS One 2012; 7. 37. Prinsloo J, Malan L, De Ridder J, et al. Determining the waist circumference cut off which best predicts the metabolic syndrome components in urban Africans: the SABPA study. Exp Clin Endocrinol Diabetes 2011; 119: 599–603. CUSTOMER CARE LINE +27 21 707 7000 www.mydynami cs.co.za TESAR CO 40/12,5, 80/12,5 mg. Each tablet contains 40, 80 mg telmisartan respectively and 12,5 mg hydrochlorothiazide. S3 A48/7.1.3/0106, 0107. For full prescribing information, refer to the professional information approved by SAHPRA, April 2021. TRCA929/05/2022. BIOEQUIVALENT TO THE ORIGINATOR TELMISARTAN/ HYDROCHLOROTHIAZIDE co 12,5 mg HCTZ T E L M I S A R T A N ON GUARD 24 30 CONVENIENTLY 30 TABLETS PACKED IN
RkJQdWJsaXNoZXIy NDIzNzc=